The effect of Goreisan to prevent the recurrence of chronic subdural hematoma
Not Applicable
- Conditions
- Chronic subdural hematoma
- Registration Number
- JPRN-UMIN000010006
- Lead Sponsor
- Saitama Medical School
- Brief Summary
The present prospective randomized study did not prove the beneficial effect of adjuvant Goreisan treatment, although it approached significance to lower the recurrence rate in overall patients. However, it suggested the importance of selecting patients with high risk of recurrence. Based on our data, a subset of patients whose hematoma showed homogeneous and separated patterns on CT image might benefit from Goreisan treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 224
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients under the age of 18 2. Patients already treated surgically before 3. Patients with possibilities to develop drug side effect
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative symptomatic reaccumulation of hematoma.
- Secondary Outcome Measures
Name Time Method